.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
AIIMS Delhi Director Dr M Srinivas recently urged stakeholders to support the nationwide HPV vaccination drive. Consequently, he called upon parents, teachers, and community leaders to promote this critical health initiative. Prime Minister Narendra Modi launched this campaign to improve public health across the country. Furthermore, the initiative has the potential to save countless lives by preventing cervical cancer. This landmark move represents a transformative moment in India's medical history.
Cervical cancer remains a leading cause of cancer deaths among women in India. However, medical experts emphasize that this disease is largely preventable through timely intervention. Scientists have validated the Human Papillomavirus (HPV) vaccine as a safe and highly effective tool. Additionally, systematic administration to girls aged 9 to 14 years provides powerful protection. Therefore, the government aims to reach girls early to ensure maximum benefit and protection.
Vaccination remains one of the most cost-effective public health interventions today. Specifically, the drive helps ease the financial burden on families. Moreover, preventive healthcare serves as the cornerstone of a resilient health system. Dr Srinivas highlighted that every eligible girl should benefit from this life-saving intervention. Collectively, these efforts envision a future where cervical cancer is no longer a public health threat.
Q1: Who is eligible for the HPV vaccine under this drive?
The current nationwide drive primarily targets adolescent girls between the ages of 9 and 14 years to ensure maximum efficacy before any potential viral exposure.
Q2: Is the HPV vaccine safe and scientifically proven?
Yes, medical professionals confirm that the HPV vaccine is safe, scientifically validated, and has been used successfully in global immunization programs for years.
Q3: Why is it important to vaccinate at a young age?
Vaccinating girls at the recommended age provides robust protection before potential exposure to the virus, significantly reducing the risk of developing cervical cancer in adulthood.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
AIIMS Delhi Director Dr M Srinivas urges support for India's nationwide HPV vaccination drive launched by PM Modi to combat cervical cancer effectively....
6 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
